249 Results

People

  1. Berger
    Berger
  2. Offit
    Offit
  3. Solit
    Solit
  4. Ladanyi
    Ladanyi
  5. Reis-Filho
    Reis-Filho
  6. Riely
    Riely
  7. Robson
    Robson
  8. Abdel-Wahab
    Abdel-Wahab
  9. Aghajanian
    Aghajanian
  10. O'Reilly
    O'Reilly

Groups

  1. Department of Medicine (136)
  2. GSK Faculty (105)
  3. Solid Tumor Oncology Division (89)
  4. Department of Pathology and Laboratory Medicine (71)
  5. Hematologic Malignancies, Division of (54)
  6. Sloan Kettering Institute Postdocs (54)
  7. Center for Hematologic Malignancies (51)
  8. Human Oncology and Pathogenesis Program (51)
  9. Tow Center for Developmental Oncology (TCDO) (48)
  10. Epidemiology and Biostatistics (42)
  1. "mutations"
Formats
  1. Journal Article (226)
  2. Review (10)
  3. Guidelines (4)
  4. Editorial (3)
  5. Meeting Abstract (3)
  6. Conference Paper (2)
  7. Research Letter (1)
Groups
  1. Department of Medicine (136)
  2. GSK Faculty (105)
  3. Solid Tumor Oncology Division (89)
  4. Department of Pathology and Laboratory Medicine (71)
  5. Hematologic Malignancies, Division of (54)
  6. Sloan Kettering Institute Postdocs (54)

More Groups

People
  1. Michael Berger (17)
  2. Kenneth Offit (15)
  3. David Solit (14)
  4. Marc Ladanyi (12)
  5. Zsofia Stadler (11)
  6. Gregory Riely (10)

More People

Years
  1. 2025 (5)
  2. 2024 (7)
  3. 2023 (19)
  4. 2022 (31)
  5. 2021 (28)
  6. 2020 (17)

More Years

Publications
  1. Clinical Cancer Research (14)
  2. JCO Precision Oncology (10)
  3. Blood (8)
  4. American Journal of Surgical Pathology (7)
  5. Cancer Discovery (7)
  6. Journal of Clinical Oncology (7)

More Publications

Publishers
  1. Nature Publishing Group (36)
  2. American Association for Cancer Research (33)
  3. Elsevier Inc. (18)
  4. American Society of Clinical Oncology (17)
  5. American Society of Hematology (15)
  6. Lippincott Williams & Wilkins (15)

More Publishers

Results (249)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • ATM germline-mutated gastroesophageal junction adenocarcinomas: Clinical descriptors, molecular characteristics, and potential therapeutic implications
    Journal Article

    El Jabbour, T.; Misyura, M.; Cowzer, D.; Zimmermann, M.; Rimkunas, V.; Marra, A.; Derakhshan, F.; Selenica, P.; Parilla, M.; Setton, J. S.; more...
    JNCI: Journal of the National Cancer Institute (2022)

    Fulltext@MSK | Save
  • Specific human endogenous retroviruses predict metastatic potential in uveal melanoma
    Journal Article

    Bendall, M. L.; Francis, J. H.; Shoushtari, A. N.; Nixon, D. F.
    JCI Insight (2022)

    Fulltext@MSK | Save
  • Risk stratification for early-onset colorectal cancer using a combination of genetic and environmental risk scores: An international multi-center study
    Journal Article

    Archambault, A. N.; Jeon, J.; Lin, Y.; Thomas, M.; Harrison, T. A.; Bishop, D. T.; Brenner, H.; Casey, G.; Chan, A. T.; Chang-Claude, J.; more...
    JNCI: Journal of the National Cancer Institute (2022)

    Fulltext@MSK | Save
  • Phase Ib trial of the combination of imatinib and binimetinib in patients with advanced gastrointestinal stromal tumors
    Journal Article

    Chi, P.; Qin, L.; Camacho, N.; Kelly, C. M.; D'Angelo, S. P.; Dickson, M. A.; Gounder, M. M.; Keohan, M. L.; Movva, S.; Nacev, B. A.; more...
    Clinical Cancer Research (2022)

    Fulltext@MSK | Save
  • First international workshop of the ATM and cancer risk group (4-5 December 2019)
    Editorial

    Lesueur, F.; Easton, D. F.; Renault, A. L.; Tavtigian, S. V.; Bernstein, J. L.; Kote-Jarai, Z.; Eeles, R. A.; Plaseska-Karanfia, D.; FeliubadaloĢ, L.; on behalf of Spanish ATM working group; more...
    Familial Cancer (2022)

    Fulltext@MSK | Save
  • Tepotinib efficacy and safety in patients with MET exon 14 skipping NSCLC: Outcomes in patient subgroups from the VISION study with relevance for clinical practice
    Journal Article

    Le, X.; Sakai, H.; Felip, E.; Veillon, R.; Garassino, M. C.; Raskin, J.; Cortot, A. B.; Viteri, S.; Mazieres, J.; Smit, E. F.; more...
    Clinical Cancer Research (2022)

    Fulltext@MSK | Save
  • Targeting mitochondrial metabolism in acute myeloid leukemia
    Review

    Rex, M. R.; Williams, R.; Birsoy, K.; Tallman, M. S.; Stahl, M.
    Leukemia and Lymphoma (2022)

    Fulltext@MSK | Save
  • SETD2 loss perturbs the kidney cancer epigenetic landscape to promote metastasis and engenders actionable dependencies on histone chaperone complexes
    Journal Article

    Xie, Y.; Sahin, M.; Sinha, S.; Wang, Y.; Nargund, A. M.; Lyu, Y.; Han, S.; Dong, Y.; Hsieh, J. J.; Leslie, C. S.; more...
    Nature Cancer (2022)

    Fulltext@MSK | Save
  • Prognostic impact of chromosomal abnormalities and copy number alterations in adult B-cell precursor acute lymphoblastic leukaemia: A UKALL14 study
    Journal Article

    Moorman, A. V.; Barretta, E.; Butler, E. R.; Ward, E. J.; Twentyman, K.; Kirkwood, A. A.; Enshaei, A.; Schwab, C.; Creasey, T.; Leongamornlert, D. A.; more...
    Leukemia (2022)

    Fulltext@MSK | Save
  • Immune biomarkers and response to checkpoint inhibition of BRAF(V600) and BRAF non-V600 altered lung cancers
    Journal Article

    Murciano-Goroff, Y. R.; Pak, T.; Mondaca, S.; Flynn, J. R.; Montecalvo, J.; Rekhtman, N.; Halpenny, D.; Plodkowski, A. J.; Wu, S. L.; Kris, M. G.; more...
    British Journal of Cancer (2022)

    Fulltext@MSK | Save